New Legislation Aims to Accelerate Slow Adoption of Biosimilars
Two new pieces of federal legislation aim to boost adoption of biosimilars — which has been slower than many hoped — by increasing public awareness of branded-biologic alternatives and making changes to the pate...
New ADHD Therapies Make Splash, Meet Payer Skepticism
Editor's note: A previous version of this article incorrectly stated that Ehave, Inc. is the manufacturer of EndeavorRx. The digital therapeutic device is made by Akili Interactive. This version has been corrected.
...
Report: Medicare Negotiation Should Target Pricey Drugs With Chart: Medicare Spends Most of Its Rx Dollars on Small Share of Drugs
An April 19 analysis by the Kaiser Family Foundation (KFF) found that a small number of drugs accounted for the majority of spending in Medicare, and that drug pricing negotiation could lower overall spending in the...
News Briefs
✦ The state budget recently unveiled by New York Gov. Andrew Cuomo (D) would delay the state’s move to carve out pharmacy benefits from its Medicaid managed care contracts, Modern Healthcare reported. Instead of...
Uber-ScriptDrop Deal Stirs Up Already Active Rx Delivery Space
Uber, seeking to expand its prescription delivery business nationwide, has inked a deal with pharmacy home delivery start-up ScriptDrop that makes Uber the default delivery app for a network of grocery store and ind...
GoodRx Benefits Patients But May Profit From ‘Broken’ System
GoodRx Inc. has captured the attention of the pharmaceutical industry by putting pricing data on patients’ smartphones, often allowing them to choose between multiple prices for one drug at the pharmacy counter. W...
Evernorth Drug Trend Report Shows Varied Pandemic Impacts With Chart: Cigna: Pandemic Led to Fewer New Scripts, Better Adherence
In the 2020 Drug Trend Report recently released by Evernorth, the Cigna Corp. division added yet another chapter to the growing volume of data detailing the profound effects that the COVID-19 pandemic has had on hea...
Vaccines Improve Public Opinion Of Pharma, Despite Cost Worries With Chart: Public Holds Favorable Views of Big Pharma, But Still Wants Drug Pricing Reforms
In recent years, the pharmaceutical industry has not been popular with the public: Problems like the rising cost of prescription drugs and the opioid epidemic combined to make the industry the least popular nationwi...
News Briefs
✦ CVS Health Corp. said on March 31 that its PBM division Caremark will “continue to serve the government-wide Service Benefit Plan” in a deal effective Jan. 1, 2022. The contract is an arrangement with carrie...
PBM and Part D Reform Could Be on Legislative Agenda
As a new bill introduced by Sen. Bernie Sanders (I-VT) indicates, Congress is once again looking seriously at tackling drug pricing reform. D.C. insiders say that Democrats could pursue big changes to PBM regulation...